Vandetanib Approved for a Rare Thyroid Cancer
Designed to extend survival in patients with late-stage diseaseContinue Reading
Designed to extend survival in patients with late-stage diseaseContinue Reading
Skin is more vulnerable to sun’s rays without hair’s protectionContinue Reading
But whether the approach beats chemo-plus-Avastin/Erbitux remains unanswered, experts sayContinue Reading
Poorer wellbeing linked to a 65% raised risk of death from any cause in study patientsContinue Reading
Increased odds of stroke, blood clots dissipate, as do most benefits, researchers findContinue Reading
Preliminary research finds no increased risk of recurrenceContinue Reading
Risk of recurrence increased with 10% gain, researchers foundContinue Reading
Imaging most often ordered for head injury, abdominal pain and headache, study findsContinue Reading
But link wasn’t seen with wine or hard liquor, researchers sayContinue Reading
Small study identified disease 83% of the time, but more research needed, experts sayContinue Reading
Genetic markers in epithelial cells seem to warn of later disease, researchers sayContinue Reading
Women with BRCA2 had best survival rate in studyContinue Reading
But the study does not prove if the association is due to the drug or other factors, expert saysContinue Reading
Researchers don’t know if vaccine to prevent cervical cancer would work for lung cancerContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.